Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis

Tocilizumab, a humanized anti-human interleukin-6 (IL-6) receptor monoclonal antibody, is beneficial for treating autoimmune conditions such as rheumatoid arthritis (RA). The most common adverse event is upper respiratory tract infection; ocular side effects are rare. We describe a case of skin ulce...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Asumi, Hashida, Noriyasu, Tanaka, Toshio, Nishida, Kohji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540646/
https://www.ncbi.nlm.nih.gov/pubmed/23424706
http://dx.doi.org/10.1155/2012/270315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540646/
https://www.ncbi.nlm.nih.gov/pubmed/23424706
http://dx.doi.org/10.1155/2012/270315

Ejemplares similares